Nit-Occlud PDA 145076V2Recalls & reported problems
pfm medical ag · Nit-Occlud® PDA is a system for transcatheter occlusion of Patent Ductus Arteriosus (PDA) with spiral coils. The system consists of a spiral coil mounted in a straightened fashion on a flexible delivery system including a disposable handle. The Nit-Occlud® PDA has a cone in cone configuration which results from the fact that the proximal windings of the coil are wound the reverse direction. Nit-Occlud® PDA is available as Flexible and Medium Type. The flexible and medium types are pre-loaded into the transportation sheath. · Class 3 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04042301159991), received between Oct 10, 2017 and Feb 6, 2019 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Activation, Positioning or Separation Problem1
- Detachment of Device or Device Component1
- Unintended Ejection1
Patient problems
- No Known Impact Or Consequence To Patient2
- Foreign Body In Patient1
- Vessel Or Plaque, Device Embedded In1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 6, 2019Detachment of Device or Device Component; Detachment of Device or Device Component
PHYSICIAN REPORTED AN AWFUL PREMATURE RELEASE. PHYSICIAN FORGOT TO CHECK THAT THE DEVICE WAS ATTACHED TO THE CABLE, WHEN THE PDA COIL (LAST LOOP) WAS DEPLOYED, THE DEVICE RELEASED. IT DID RELEASE IN A GOOD POSITION, WAS STABLE, AND THE SHUNT DIMINISHED TO TRIVIAL WITH RESOLUTION OF THE MURMUR IN 12 MINUTES. THE PHYSICIAN DID NOT NOTICE HIGH RESISTANCE DURING FORWARDING OF THE SYSTEM INTO THE IMPLANTATION CATHETER. PHYSICIAN DID NOT NOTICE A GAP BETWEEN PUSHER AND COIL PRIOR TO RELEASE. IF ISSUE RECURRED IT COULD LEAD TO EMBOLIZATION OF THE DEVICE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8313090 ↗MalfunctionFeb 6, 2019Unintended Ejection; Unintended Ejection
THE COIL SEPARATED FROM THE DELIVERY SYSTEM WHILE IN THE CATHETER. IT WAS RETRIEVED WITHOUT INCIDENT. PHYSICIAN CONFIGURED COIL IN THE DESCENDING AORTA, PULLED SYSTEM BACK INTO DEFECT, SUSPECTED POTENTIAL COARC AND DECIDED TO RETRIEVE / RE-CONFIGURE. UPON SHEATH RE-ENTRY, COIL DETACHED FROM MANDREL WIRE. A 5X4 ADO I WAS USED TO COMPLETE THE PROCEDURE. PHYSICIAN DID NOT NOTICE HIGH RESISTANCE DURING FORWARDING OR RETRIEVAL OF THE SYSTEM INTO THE IMPLANTATION CATHETER. CURVATURE OF THE IMPLANTATION CATHETER IN THE VESSEL WAS MILD. THE PHYSICIAN DID NOT NOTICE A GAP BETWEEN THE PUSHER AND COIL PRIOR TO RELEASE. THE PHYSICIAN DID NOT MOVE THE ROTATION SCREW FORWARD AT ALL. IN THE FILM, A GAP IS NOTICEABLE BETWEEN THE PUSHER WIRE AND THE DEVICE; APPROXIMATELY 1CM OR MORE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8313083 ↗MalfunctionOct 10, 2017Activation, Positioning or Separation Problem; Activation, Positioning or Separation Problem
WHEN THE COIL WAS EXTRUDED INTO THE PROXIMAL DESCENDING AORTA, THE LEADING EDGE LODGED ITSELF INTO THE AORTA. IT WAS EXTREMELY DIFFICULT TO GET OUT. DURING THE PROCESS OF ATTEMPTING TO REMOVE IT (USING CATHETERS FROM THE ARTERIAL SIDE TO PRY IT AWAY FROM THE AORTA, AS WELL AS PULLING WITH A SNARE), THERE WAS PREMATURE RELEASE OF THE DELIVERY SYSTEM FROM THE DEVICE. AT THAT POINT, DEVICE WAS HALF WITHIN THE CATHETER AND HALF OUTSIDE. PHYSICIAN WAS ABLE TO SNARE IT AND PULL IT OFF THE AORTA, AND SUBSEQUENTLY PULLED BOTH THE SNARE AND DELIVERY CATHETER BACK THROUGH THE PDA INTO THE MAIN PULMONARY ARTERY AND THEN TO THE IVC WHERE IT COULD BE DEALT WITH BETTER WITHOUT RISK OF DANGEROUS EMBOLIZATION. ONCE THERE WITHIN THE IVC, PHYSICIAN WAS ABLE TO GET A BETTER HOLD WITH THE SNARE AND PULLED IT INTO THE SHEATH. SOME CAME THROUGH AND THEN, WHILE PULLING, THE COIL BROKE IN HALF. PHYSICIAN WAS ABLE TO WITHDRAW FIRST HALF, AND THEN RE-SNARE THE REMAINING HALF AND REMOVE IT. PHYSICIAN THEN PLACED THE NEXT SIZE NIT-OCCLUD COIL AND EXTRUDED IT INTO DESCENDING AORTA. UPON PULLING BACK INTO THE AMPULLA, IT EASILY PULLED ACROSS THE PDA INTO THE PULMONARY ARTERY DESPITE HAVING REPEATED AN ANGIOGRAM
Patient problems: Foreign Body In Patient; Vessel Or Plaque, Device Embedded In
MAUDE report 6938883 ↗
Other Occluder, Patent Ductus, Arteriosus devices
- Amplatzer™ 9-PDA-005St. Jude Medical, Inc. · OCCLUDER, PATENT DUCTUS, ARTERIOSUS79 reports
- Amplatzer™ 9-PDA-004St. Jude Medical, Inc. · OCCLUDER, PATENT DUCTUS, ARTERIOSUS45 reports
- Amplatzer Piccolo™ 9-PDAP-05-04-LSt. Jude Medical, Inc. · OCCLUDER, PATENT DUCTUS, ARTERIOSUS1 death45 reports
- Amplatzer Piccolo™ 9-PDAP-05-02-LSt. Jude Medical, Inc. · OCCLUDER, PATENT DUCTUS, ARTERIOSUS4 deaths43 reports
- Amplatzer Piccolo™ 9-PDAP-04-02-LSt. Jude Medical, Inc. · OCCLUDER, PATENT DUCTUS, ARTERIOSUS7 deaths31 reports
- Amplatzer™ 9-PDA-006St. Jude Medical, Inc. · OCCLUDER, PATENT DUCTUS, ARTERIOSUS26 reports
- Amplatzer™ 9-PDA-003St. Jude Medical, Inc. · OCCLUDER, PATENT DUCTUS, ARTERIOSUS1 death24 reports
- Amplatzer Piccolo™ 9-PDAP-04-04-LSt. Jude Medical, Inc. · OCCLUDER, PATENT DUCTUS, ARTERIOSUS3 deaths24 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page